APO Research
Talk to an analyst

APO RESEARCH · REPORT

Digital Insomnia Therapeutics

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Digital Insomnia Therapeutics Market Outlook and Growth Opportunities 2026

11 April 2026Not stated

Choose your research edition.

Industry ResearchDigital Insomnia Therapeutics Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Digital Insomnia Therapeutics Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Digital Insomnia Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Digital Insomnia Therapeutics Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Digital Insomnia Therapeutics Market Analysis and Forecast 2026-2032225 pages · $4,950 USD

Market perspective

The global Digital Insomnia Therapeutics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Digital Insomnia Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Digital Insomnia Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Digital Insomnia Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Digital Insomnia Therapeutics market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Digital Insomnia Therapeutics market include Headspace Inc, Big Health, Calm, Nox Health, Pear Therapeutics, OPTT Inc, SilverCloud, Curv Health and Bodymatter Inc, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Digital Insomnia Therapeutics market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Digital Insomnia Therapeutics and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Digital Insomnia Therapeutics revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Digital Insomnia Therapeutics market.

Digital Insomnia Therapeutics Segment by Company

Headspace Inc

Big Health

Calm

Nox Health

Pear Therapeutics

OPTT Inc

SilverCloud

Curv Health

Bodymatter Inc

PrimeNap

Digital Insomnia Therapeutics Segment by Type

Sleep Tracking App

Relaxation and Meditation Apps

CBT-I

Others

Digital Insomnia Therapeutics Segment by Application

Medical

Household

Digital Insomnia Therapeutics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Digital Insomnia Therapeutics status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Digital Insomnia Therapeutics key companies, revenue, market share, and recent developments.

3. To split the Digital Insomnia Therapeutics breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Digital Insomnia Therapeutics market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Digital Insomnia Therapeutics significant trends, drivers, influence factors in global and regions.

6. To analyze Digital Insomnia Therapeutics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digital Insomnia Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Digital Insomnia Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digital Insomnia Therapeutics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Digital Insomnia Therapeutics industry.

Chapter 3: Detailed analysis of Digital Insomnia Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Digital Insomnia Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Digital Insomnia Therapeutics in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Digital Insomnia Therapeutics Industry Trends Table 2. Digital Insomnia Therapeutics Industry Drivers Table 3. Digital Insomnia Therapeutics Industry Opportunities and Challenges Table 4. Digital Insomnia Therapeutics Industry Restraints Table 5. Global Digital Insomnia Therapeutics Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Digital Insomnia Therapeutics Revenue Share by Company (2021-2026) Table 7. Global Digital Insomnia Therapeutics Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Digital Insomnia Therapeutics Key Company Manufacturing Base & Headquarters Table 9. Global Digital Insomnia Therapeutics Company, Product Type & Application Table 10. Global Digital Insomnia Therapeutics Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Digital Insomnia Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Sleep Tracking App Table 15. Significant Companies of Relaxation and Meditation Apps Table 16. Significant Companies of CBT-I Table 17. Significant Companies of Others Table 18. Global Digital Insomnia Therapeutics Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Digital Insomnia Therapeutics Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Digital Insomnia Therapeutics Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Digital Insomnia Therapeutics Sales Value Share by Type (2021-2026) Table 22. Global Digital Insomnia Therapeutics Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Medical Table 24. Significant Companies of Household Table 25. Global Digital Insomnia Therapeutics Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Digital Insomnia Therapeutics Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Digital Insomnia Therapeutics Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Digital Insomnia Therapeutics Sales Value Share by Application (2021-2026) Table 29. Global Digital Insomnia Therapeutics Sales Value Share by Application (2027-2032) Table 30. Global Digital Insomnia Therapeutics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Digital Insomnia Therapeutics Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Digital Insomnia Therapeutics Sales Value Share by Region (2021-2026) Table 33. Global Digital Insomnia Therapeutics Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Digital Insomnia Therapeutics Sales Value Share by Region (2027-2032) Table 35. Global Digital Insomnia Therapeutics Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Digital Insomnia Therapeutics Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Digital Insomnia Therapeutics Sales Value Market Share by Country (2021-2026) Table 38. Global Digital Insomnia Therapeutics Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Digital Insomnia Therapeutics Sales Value Market Share by Country (2027-2032) Table 40. Headspace Inc Company Information Table 41. Headspace Inc Business Overview Table 42. Headspace Inc Digital Insomnia Therapeutics Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Headspace Inc Digital Insomnia Therapeutics Product Portfolio Table 44. Headspace Inc Recent Development Table 45. Big Health Company Information Table 46. Big Health Business Overview Table 47. Big Health Digital Insomnia Therapeutics Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Big Health Digital Insomnia Therapeutics Product Portfolio Table 49. Big Health Recent Development Table 50. Calm Company Information Table 51. Calm Business Overview Table 52. Calm Digital Insomnia Therapeutics Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Calm Digital Insomnia Therapeutics Product Portfolio Table 54. Calm Recent Development Table 55. Nox Health Company Information Table 56. Nox Health Business Overview Table 57. Nox Health Digital Insomnia Therapeutics Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Nox Health Digital Insomnia Therapeutics Product Portfolio Table 59. Nox Health Recent Development Table 60. Pear Therapeutics Company Information Table 61. Pear Therapeutics Business Overview Table 62. Pear Therapeutics Digital Insomnia Therapeutics Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Pear Therapeutics Digital Insomnia Therapeutics Product Portfolio Table 64. Pear Therapeutics Recent Development Table 65. OPTT Inc Company Information Table 66. OPTT Inc Business Overview Table 67. OPTT Inc Digital Insomnia Therapeutics Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. OPTT Inc Digital Insomnia Therapeutics Product Portfolio Table 69. OPTT Inc Recent Development Table 70. SilverCloud Company Information Table 71. SilverCloud Business Overview Table 72. SilverCloud Digital Insomnia Therapeutics Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. SilverCloud Digital Insomnia Therapeutics Product Portfolio Table 74. SilverCloud Recent Development Table 75. Curv Health Company Information Table 76. Curv Health Business Overview Table 77. Curv Health Digital Insomnia Therapeutics Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Curv Health Digital Insomnia Therapeutics Product Portfolio Table 79. Curv Health Recent Development Table 80. Bodymatter Inc Company Information Table 81. Bodymatter Inc Business Overview Table 82. Bodymatter Inc Digital Insomnia Therapeutics Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Bodymatter Inc Digital Insomnia Therapeutics Product Portfolio Table 84. Bodymatter Inc Recent Development Table 85. PrimeNap Company Information Table 86. PrimeNap Business Overview Table 87. PrimeNap Digital Insomnia Therapeutics Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. PrimeNap Digital Insomnia Therapeutics Product Portfolio Table 89. PrimeNap Recent Development Table 90. Research Programs/Design for This Report Table 91. Authors List of This Report Table 92. Secondary Sources Table 93. Primary Sources List of Figures Figure 1. Digital Insomnia Therapeutics Product Image Figure 2. Global Digital Insomnia Therapeutics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Digital Insomnia Therapeutics Market Size (2021-2032) & (US$ Million) Figure 4. Global Digital Insomnia Therapeutics Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Sleep Tracking App Image Figure 8. Relaxation and Meditation Apps Image Figure 9. CBT-I Image Figure 10. Others Image Figure 11. Global Digital Insomnia Therapeutics Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Digital Insomnia Therapeutics Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Digital Insomnia Therapeutics Sales Value Share by Type (2021-2032) Figure 14. Medical Image Figure 15. Household Image Figure 16. Global Digital Insomnia Therapeutics Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Digital Insomnia Therapeutics Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Digital Insomnia Therapeutics Sales Value Share by Application (2021-2032) Figure 19. Global Digital Insomnia Therapeutics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Digital Insomnia Therapeutics Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Digital Insomnia Therapeutics Sales Value (2021-2032) & (US$ Million) Figure 22. North America Digital Insomnia Therapeutics Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Digital Insomnia Therapeutics Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Digital Insomnia Therapeutics Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Digital Insomnia Therapeutics Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Digital Insomnia Therapeutics Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Digital Insomnia Therapeutics Sales Value (2021-2032) & (US$ Million) Figure 28. South America Digital Insomnia Therapeutics Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Digital Insomnia Therapeutics Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Digital Insomnia Therapeutics Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Sleep Tracking App
  • Relaxation and Meditation Apps
  • CBT-I
  • Others
Applications
  • Medical
  • Household
Companies covered
  • Headspace Inc
  • Big Health
  • Calm
  • Nox Health
  • Pear Therapeutics
  • OPTT Inc
  • SilverCloud
  • Curv Health
  • Bodymatter Inc
  • PrimeNap

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Digital Insomnia Therapeutics Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Digital Insomnia Therapeutics Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Digital Insomnia Therapeutics Market Dynamics
  1. 2.1 Digital Insomnia Therapeutics Industry Trends
  2. 2.2 Digital Insomnia Therapeutics Industry Drivers
  3. 2.3 Digital Insomnia Therapeutics Industry Opportunities and Challenges
  4. 2.4 Digital Insomnia Therapeutics Industry Restraints
3 Digital Insomnia Therapeutics Market by Company
  1. 3.1 Global Digital Insomnia Therapeutics Company Revenue Ranking in 2025
  2. 3.2 Global Digital Insomnia Therapeutics Revenue by Company (2021-2026)
  3. 3.3 Global Digital Insomnia Therapeutics Company Ranking (2024-2026)
  4. 3.4 Global Digital Insomnia Therapeutics Company Manufacturing Base and Headquarters
  5. 3.5 Global Digital Insomnia Therapeutics Company Product Type and Application
  6. 3.6 Global Digital Insomnia Therapeutics Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Digital Insomnia Therapeutics Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Digital Insomnia Therapeutics Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Digital Insomnia Therapeutics Market by Type
  1. 4.1 Digital Insomnia Therapeutics Type Introduction
  2. 4.1.1 Sleep Tracking App
  3. 4.1.2 Relaxation and Meditation Apps
  4. 4.1.3 CBT-I
  5. 4.1.4 Others
  6. 4.2 Global Digital Insomnia Therapeutics Sales Value by Type
  7. 4.2.1 Global Digital Insomnia Therapeutics Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Digital Insomnia Therapeutics Sales Value by Type (2021-2032)
  9. 4.2.3 Global Digital Insomnia Therapeutics Sales Value Share by Type (2021-2032)
5 Digital Insomnia Therapeutics Market by Application
  1. 5.1 Digital Insomnia Therapeutics Application Introduction
  2. 5.1.1 Medical
  3. 5.1.2 Household
  4. 5.2 Global Digital Insomnia Therapeutics Sales Value by Application
  5. 5.2.1 Global Digital Insomnia Therapeutics Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Digital Insomnia Therapeutics Sales Value by Application (2021-2032)
  7. 5.2.3 Global Digital Insomnia Therapeutics Sales Value Share by Application (2021-2032)
6 Digital Insomnia Therapeutics Regional Value Analysis
  1. 6.1 Global Digital Insomnia Therapeutics Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Digital Insomnia Therapeutics Sales Value by Region (2021-2032)
  3. 6.2.1 Global Digital Insomnia Therapeutics Sales Value by Region: 2021-2026
  4. 6.2.2 Global Digital Insomnia Therapeutics Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Digital Insomnia Therapeutics Sales Value (2021-2032)
  7. 6.3.2 North America Digital Insomnia Therapeutics Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Digital Insomnia Therapeutics Sales Value (2021-2032)
  10. 6.4.2 Europe Digital Insomnia Therapeutics Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Digital Insomnia Therapeutics Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Digital Insomnia Therapeutics Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Digital Insomnia Therapeutics Sales Value (2021-2032)
  16. 6.6.2 South America Digital Insomnia Therapeutics Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Digital Insomnia Therapeutics Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Digital Insomnia Therapeutics Sales Value Share by Country, 2025 VS 2032
7 Digital Insomnia Therapeutics Country-level Value Analysis
  1. 7.1 Global Digital Insomnia Therapeutics Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Digital Insomnia Therapeutics Sales Value by Country (2021-2032)
  3. 7.2.1 Global Digital Insomnia Therapeutics Sales Value by Country (2021-2026)
  4. 7.2.2 Global Digital Insomnia Therapeutics Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Digital Insomnia Therapeutics Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Digital Insomnia Therapeutics Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Digital Insomnia Therapeutics Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Headspace Inc
  2. 8.1.1 Headspace Inc Company Information
  3. 8.1.2 Headspace Inc Business Overview
  4. 8.1.3 Headspace Inc Digital Insomnia Therapeutics Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Headspace Inc Digital Insomnia Therapeutics Product Portfolio
  6. 8.1.5 Headspace Inc Recent Developments
  7. 8.2 Big Health
  8. 8.2.1 Big Health Company Information
  9. 8.2.2 Big Health Business Overview
  10. 8.2.3 Big Health Digital Insomnia Therapeutics Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Big Health Digital Insomnia Therapeutics Product Portfolio
  12. 8.2.5 Big Health Recent Developments
  13. 8.3 Calm
  14. 8.3.1 Calm Company Information
  15. 8.3.2 Calm Business Overview
  16. 8.3.3 Calm Digital Insomnia Therapeutics Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Calm Digital Insomnia Therapeutics Product Portfolio
  18. 8.3.5 Calm Recent Developments
  19. 8.4 Nox Health
  20. 8.4.1 Nox Health Company Information
  21. 8.4.2 Nox Health Business Overview
  22. 8.4.3 Nox Health Digital Insomnia Therapeutics Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Nox Health Digital Insomnia Therapeutics Product Portfolio
  24. 8.4.5 Nox Health Recent Developments
  25. 8.5 Pear Therapeutics
  26. 8.5.1 Pear Therapeutics Company Information
  27. 8.5.2 Pear Therapeutics Business Overview
  28. 8.5.3 Pear Therapeutics Digital Insomnia Therapeutics Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Pear Therapeutics Digital Insomnia Therapeutics Product Portfolio
  30. 8.5.5 Pear Therapeutics Recent Developments
  31. 8.6 OPTT Inc
  32. 8.6.1 OPTT Inc Company Information
  33. 8.6.2 OPTT Inc Business Overview
  34. 8.6.3 OPTT Inc Digital Insomnia Therapeutics Revenue and Gross Margin (2021-2026)
  35. 8.6.4 OPTT Inc Digital Insomnia Therapeutics Product Portfolio
  36. 8.6.5 OPTT Inc Recent Developments
  37. 8.7 SilverCloud
  38. 8.7.1 SilverCloud Company Information
  39. 8.7.2 SilverCloud Business Overview
  40. 8.7.3 SilverCloud Digital Insomnia Therapeutics Revenue and Gross Margin (2021-2026)
  41. 8.7.4 SilverCloud Digital Insomnia Therapeutics Product Portfolio
  42. 8.7.5 SilverCloud Recent Developments
  43. 8.8 Curv Health
  44. 8.8.1 Curv Health Company Information
  45. 8.8.2 Curv Health Business Overview
  46. 8.8.3 Curv Health Digital Insomnia Therapeutics Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Curv Health Digital Insomnia Therapeutics Product Portfolio
  48. 8.8.5 Curv Health Recent Developments
  49. 8.9 Bodymatter Inc
  50. 8.9.1 Bodymatter Inc Company Information
  51. 8.9.2 Bodymatter Inc Business Overview
  52. 8.9.3 Bodymatter Inc Digital Insomnia Therapeutics Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Bodymatter Inc Digital Insomnia Therapeutics Product Portfolio
  54. 8.9.5 Bodymatter Inc Recent Developments
  55. 8.10 PrimeNap
  56. 8.10.1 PrimeNap Company Information
  57. 8.10.2 PrimeNap Business Overview
  58. 8.10.3 PrimeNap Digital Insomnia Therapeutics Revenue and Gross Margin (2021-2026)
  59. 8.10.4 PrimeNap Digital Insomnia Therapeutics Product Portfolio
  60. 8.10.5 PrimeNap Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst